Ozenoxacin

(Xepi)

Ozenoxacin

Drug updated on 11/14/2023

Dosage FormCream (topical: 1%)
Drug ClassQuinolone antimicrobials
Ongoing and Completed StudiesClinicalTrials.gov

Indication

  • For the topical treatment of impetigo due to Staphylococcus aureus Streptococcus pyogenes or in adult and pediatric patients 2 months of age and older.

Product Monograph / Prescribing Information

Document TitleYearSource
Xepi (ozenoxacin) Prescribing Information.2020FDA

Systematic Reviews / Meta-Analyses